NasdaqCM - Delayed Quote USD

Oncolytics Biotech Inc. (ONCY)

0.3399
-0.0071
(-2.05%)
At close: June 4 at 4:00:00 PM EDT
0.3504
+0.01
+(3.09%)
After hours: June 4 at 7:13:55 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
33,255
34,982
33,791
26,924
26,235
Operating Income
-33,255
-34,982
-33,791
-26,924
-26,235
Net Non Operating Interest Income Expense
876
1,199
1,326
528
99
Other Income Expense
1,006
2,203
4,810
1,645
-119
Pretax Income
-31,373
-31,580
-27,655
-24,751
-26,255
Tax Provision
--
130
97
84
49
Net Income Common Stockholders
-31,503
-31,710
-27,752
-24,835
-26,304
Diluted NI Available to Com Stockholders
-31,503
-31,710
-27,752
-24,835
-26,304
Basic EPS
-0.40
-0.41
-0.41
-0.43
-0.49
Diluted EPS
-0.40
-0.41
-0.41
-0.43
-0.49
Basic Average Shares
78,829.6160
76,482.9140
67,624.0360
58,029.7450
53,513.2250
Diluted Average Shares
78,829.6160
76,482.9140
67,624.0360
58,029.7450
53,513.2250
Total Operating Income as Reported
--
--
--
--
-26,234.9450
Total Expenses
33,255
34,982
33,791
26,924
26,235
Net Income from Continuing & Discontinued Operation
-31,503
-31,710
-27,752
-24,835
-26,304
Normalized Income
-32,509
-33,582.5500
-30,638
-26,048.8455
-26,216.5350
Interest Income
876
1,199
1,326
528
99
Net Interest Income
876
1,199
1,326
528
99
EBIT
-33,255
-34,982
-33,791
-26,924
-26,235
EBITDA
-32,857
-34,558
-33,388
-26,532
-25,783
Reconciled Depreciation
398
424
403
392
452
Net Income from Continuing Operation Net Minority Interest
-31,503
-31,710
-27,752
-24,835
-26,304
Total Unusual Items Excluding Goodwill
1,006
2,203
4,810
1,645
-119
Total Unusual Items
1,006
2,203
4,810
1,645
-119
Normalized EBITDA
-33,863
-36,761
-38,198
-28,177
-25,664
Tax Rate for Calcs
0
0.0002
0.0004
0.0003
0.0003
Tax Effect of Unusual Items
0
330.4500
1,924
431.1545
-31.5350
12/31/2021 - 10/5/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RANI Rani Therapeutics Holdings, Inc.
0.5599
+0.97%
 
VTVT vTv Therapeutics Inc.
16.00
-1.84%
 
CNTX Context Therapeutics Inc.
0.5753
-1.15%
 
CDTX Cidara Therapeutics, Inc.
24.05
+3.22%
 
HOWL Werewolf Therapeutics, Inc.
1.3100
-3.68%
 
CYCC Cyclacel Pharmaceuticals, Inc.
1.4500
-13.17%
 
SGMO Sangamo Therapeutics, Inc.
0.4920
-1.64%
 
CGTX Cognition Therapeutics, Inc.
0.3076
-0.74%
 
KAPA Kairos Pharma, Ltd.
0.5206
+15.69%
 
INTS Intensity Therapeutics, Inc.
0.4720
-10.10%